A case of PD-L1-positive pulmonary sarcomatoid carcinoma treated with sindilizumab in combination with anilotinib and literature review
This article reports on a 78-year-old male patient with advanced pulmonary sarcomatoid car-cinoma with positive PD-L1 expression,who achieved partial remission(PR)and progression-free survival(PFS)of 30 months with sindilizumab and amilorotinib.Grade 2 hypertension and other transient cardiac problems occurred during treatment,but overall quality of life was good.
万方数据
维普
